• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Nuvo Research Inc

+ Add to Watchlist

NRI:CN

4.4800 CAD 0.2400 5.66%

As of 16:19:39 ET on 09/19/2014.

Snapshot for Nuvo Research Inc (NRI)

Open: 4.2400 Day's Range: 4.2300 - 4.5000 Volume: 163,675
Previous Close: 4.2400 52wk Range: 1.5800 - 5.7300 1-Yr Rtn: +122.89%

Stock Chart for NRI

No chart data available.
  • NRI:CN 4.4800
  • 1D
  • 1M
  • 1Y
4.2400
Interactive NRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NRI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.5600
Est. EPS (CAD) (12/2014) -
Est. PEG Ratio -
Market Cap (M CAD) 45.87
Shares Outstanding (M) 10.24
30 Day Average Volume 44,474
Price/Book (mrq) 3.6756
Price/Sale (ttm) 2.0733
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NRI

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for NRI

Nuvo Research Inc. manufactures drugs in Canada and Germany. The Company develops and manufactures products aimed at treatment options for arthritis, skin conditions, certain cancers, immune system response, and the therapeutic management of chronic viral infections.

Daniel H ChicoineChairman/Co-CEOJohn C LondonPresident/Co-CEO
Henrich R K GuntermannPresident:Europe & ImmunologyStephen L LemieuxVP/CFO
More Company Profile & Key Executives for NRI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil